← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2000Last known activity
Jun 6, 2023
Timeline
1860s
- Mar 2, 1867
Howard University— Founded
Drugs by trial phase (18 distinct, 13 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Anemia
- Anemia, Sickle Cell
- Behavior, Addictive
- Bipolar Disorder
- Disease
- Hematologic Diseases
- HIV Infections
- Immunologic Deficiency Syndromes
- Melanosis
- Opioid-Related Disorders
- Parkinson Disease
- Prostatic Neoplasms
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Substance-Related Disorders
Recent trials (19)
- NCT05806164CollaboratorPhase 4Jun 6, 2023
- NCT04749576Study chairN/ADec 15, 2020
- NCT04749576Lead sponsorN/ADec 15, 2020
- NCT03865121CollaboratorPhase 2Mar 4, 2019
- NCT03861832Reponsible party - principal investigatorN/AJun 16, 2018
- NCT03861832Lead sponsorN/AJun 16, 2018
- NCT02849548Lead sponsorPhase 4Jan 3, 2017
- NCT02849548Overall official - principal investigatorPhase 4Jan 3, 2017
- NCT02704754Overall official - principal investigatorPhase 4May 1, 2016
- NCT02704754Lead sponsorPhase 4May 1, 2016
- NCT03583138Overall official - principal investigatorPhase 4Jun 23, 2014
- NCT03583138CollaboratorPhase 4Jun 23, 2014
- NCT01550341CollaboratorN/AApr 1, 2012
- NCT01550341Overall official - principal investigatorN/AApr 1, 2012
- NCT01317199CollaboratorPhase 1/Phase 2Jul 1, 2011
Details
- Founded
- Washington, DC, US Mar 2, 1867
- Last known activity
- Jun 6, 2023